查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953988

日本基因治療市場報告：按基因類型、載體類型、遞送方式、應用和地區分類（2026-2034年）

Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本基因治療市場規模達3.918億美元。 IMARC Group預測，到2034年，該市場規模將達到12.248億美元，2026年至2034年的複合年成長率（CAGR）為13.10%。遺傳疾病的日益增加、基因編輯技術的最新進展、日本政府的支持性政策以及研發投入的增加是推動市場成長的主要因素。

基因療法是一種突破性的醫療方法，旨在透過修改個別細胞內的基因來治療甚至根除疾病。這項先進技術涉及在患者細胞內引入、刪除或改變遺傳物質，主要用於糾正導致各種疾病的基因異常。基因療法的關鍵組成部分包括治療性去氧核糖核酸（DNA）、將DNA導入細胞的遞送載體以及CRISPR等先進的基因編輯技術。其潛在應用包括癌症治療、病毒感染疾病控制、心血管疾病（CVD）、神經系統疾病、自體免疫疾病、老齡化相關疾病、某些類型的失明以及血友病、囊腫纖維化和鐮狀細胞貧血等遺傳性疾病。

日本基因治療市場的發展趨勢：

日本遺傳性疾病和癌症的日益普遍推動了對基因治療等創新治療方法的需求，進而促進了市場成長。此外，CRISPR/Cas9等基因編輯技術的最新進展提高了基因修飾的精確度和治療成功率，進一步促進了市場成長。製藥和生物技術公司為開發高效創新的基因治療方法而投入大量資金進行研發，也推動了市場成長。同時，日本政府實施了一系列支持性的監管和政策措施，加速基因療法的核准流程，促進臨床試驗和產品的開發，也刺激了市場成長。此外，先進載體遞送系統的出現提高了基因治療的療效，最大限度地減少了潛在的副作用，從而提供了更有效、更安全的治療選擇，也支持了市場成長。此外，醫療專業人員和患者對基因治療及其潛在益處的認知不斷提高，也增強了市場成長。除此之外，大學、研究機構和企業之間為促進創新和拓展商業化可能性而加強的策略聯盟與合作，也推動了市場成長。此外，老年人口的增加也推動了市場成長，老年人容易患上各種與老齡化相關的疾病，例如帕金森氏症、骨關節炎、阿茲海默症、老齡化黃斑部病變（AMD）等。預計推動市場成長的其他因素包括醫療保健支出增加、精準醫療的日益普及以及對創新治療方法的需求不斷成長。

日本基因治療市場細分：

基因分型分析：

  • 抗原
  • 細胞激素
  • 腫瘤抑制基因
  • 自殺基因
  • 不足
  • 生長因子
  • 受體
  • 其他

向量類型概述：

  • 病毒載體
  • 腺病毒
  • 慢病毒
  • 逆轉錄病毒
  • 腺結合病毒
  • 單純皰疹病毒
  • 天花病毒
  • 牛痘病毒
  • 其他
  • 非病毒方法
  • 裸載體和質體載體
  • 基因槍
  • 電穿孔
  • 脂質體
  • 其他
  • 腺病毒
  • 慢病毒
  • 逆轉錄病毒
  • 腺結合病毒
  • 單純皰疹病毒
  • 天花病毒
  • 牛痘病毒
  • 其他
  • 裸病毒和質體載體
  • 基因癌症
  • 電穿孔
  • 脂質體
  • 其他

配送方式註意事項：

  • 體內基因治療
  • 體外基因治療

應用注意事項：

  • 腫瘤性疾病
  • 罕見疾病
  • 心血管疾病
  • 神經系統疾病
  • 感染疾病

區域洞察：

  • 關東地區
  • 近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區
  • 本報告對所有主要區域市場進行了全面分析，包括關東、近畿地區、中部、九州/沖繩、東北、中國、北海道和四國地區。

競爭格局：

  • 本報告也對日本基因治療市場的競爭格局進行了全面分析。報告提供了競爭分析，包括市場結構、主要企業定位、關鍵成功策略、競爭格局概覽和公司評估象限。此外，報告還提供了所有主要企業的詳細概況。
  • 本報告解答的關鍵問題
  • 日本基因治療市場目前發展狀況如何？您認為未來幾年它將如何發展？
  • 新冠疫情對日本基因治療市場產生了哪些影響？
  • 日本基因治療市場按基因類型分類的市場組成為何？
  • 日本基因治療市場依載體類型分類的組成是怎樣的？
  • 日本基因治療市場按給藥方式分類的市場組成為何？
  • 日本基因治療市場按應用領域是如何分類的？
  • 請介紹日本基因治療市場價值鏈的各個環節。
  • 日本基因治療市場的主要促進因素和挑戰是什麼？
  • 日本基因治療市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本基因治療市場競爭有多激烈？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本基因治療市場：簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本基因治療市場：現況

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章 日本基因治療市場－依基因類型分類

  • 抗原
  • 細胞激素
  • 腫瘤抑制基因
  • 自殺基因
  • 不足
  • 生長因子
  • 受體
  • 其他

第7章 日本基因治療市場－依載體類型細分

  • 病毒載體
  • 非病毒技術

第8章：日本基因治療市場－依給藥方式細分

  • 體內基因治療
  • 體外基因治療

第9章：日本基因治療市場：依應用領域細分

  • 腫瘤性疾病
  • 罕見疾病
  • 循環系統疾病
  • 神經系統疾病
  • 感染疾病
  • 其他

第10章：日本基因治療市場：依地區分類

  • 關東地區
  • 近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第11章：日本基因治療市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第12章主要企業概況

第13章：日本基因治療市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第14章附錄

簡介目錄
Product Code: SR112026A9327

The Japan gene therapy market size reached USD 391.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1224.8 Million by 2034, exhibiting a growth rate (CAGR) of 13.10% during 2026-2034. The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.

Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.

JAPAN GENE THERAPY MARKET TRENDS:

The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.

JAPAN GENE THERAPY MARKET SEGMENTATION:

Gene Type Insights:

  • Antigen
  • Cytokine
  • Tumor Suppressor
  • Suicide Gene
  • Deficiency
  • Growth Factors
  • Receptors
  • Others

Vector Type Insights:

  • Viral Vector
  • Adenoviruses
  • Lentiviruses
  • Retroviruses
  • Adeno-Associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
  • Others
  • Non-Viral Techniques
  • Naked and Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection
  • Others
  • Adenoviruses
  • Lentiviruses
  • Retroviruses
  • Adeno-Associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
  • Others
  • Naked and Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection
  • Others

Delivery Method Insights:

  • In-Vivo Gene Therapy
  • Ex-Vivo Gene Therapy

Application Insights:

  • Oncological Disorders
  • Rare diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Infectious Disease

Regional Insights:

  • Kanto Region
  • Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

  • The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan gene therapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan gene therapy market?
  • What is the breakup of the Japan gene therapy market on the basis of gene type?
  • What is the breakup of the Japan gene therapy market on the basis of vector type?
  • What is the breakup of the Japan gene therapy market on the basis of delivery method?
  • What is the breakup of the Japan gene therapy market on the basis of application?
  • What are the various stages in the value chain of the Japan gene therapy market?
  • What are the key driving factors and challenges in the Japan gene therapy market?
  • What is the structure of the Japan gene therapy market and who are the key players?
  • What is the degree of competition in the Japan gene therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Gene Therapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Gene Therapy Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Gene Therapy Market - Breakup by Gene Type

  • 6.1 Antigen
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Cytokine
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Tumor Suppressor
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Suicide Gene
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Deficiency
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Growth Factors
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Receptors
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2020-2025)
    • 6.8.3 Market Forecast (2026-2034)

7 Japan Gene Therapy Market - Breakup by Vector Type

  • 7.1 Viral Vector
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Adenoviruses
      • 7.1.3.2 Lentiviruses
      • 7.1.3.3 Retroviruses
      • 7.1.3.4 Adeno-Associated Virus
      • 7.1.3.5 Herpes Simplex Virus
      • 7.1.3.6 Poxvirus
      • 7.1.3.7 Vaccinia Virus
      • 7.1.3.8 Others
    • 7.1.4 Market Forecast (2026-2034)
  • 7.2 Non-Viral Techniques
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Naked and Plasmid Vectors
      • 7.2.3.2 Gene Gun
      • 7.2.3.3 Electroporation
      • 7.2.3.4 Lipofection
      • 7.2.3.5 Others
    • 7.2.4 Market Forecast (2026-2034)

8 Japan Gene Therapy Market - Breakup by Delivery Method

  • 8.1 In-Vivo Gene Therapy
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Ex-Vivo Gene Therapy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Gene Therapy Market - Breakup by Application

  • 9.1 Oncological Disorders
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Rare Diseases
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Cardiovascular Diseases
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Neurological Disorders
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Infectious Disease
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Forecast (2026-2034)

10 Japan Gene Therapy Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Gene Type
    • 10.1.4 Market Breakup by Vector Type
    • 10.1.5 Market Breakup by Delivery Method
    • 10.1.6 Market Breakup by Application
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Gene Type
    • 10.2.4 Market Breakup by Vector Type
    • 10.2.5 Market Breakup by Delivery Method
    • 10.2.6 Market Breakup by Application
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Gene Type
    • 10.3.4 Market Breakup by Vector Type
    • 10.3.5 Market Breakup by Delivery Method
    • 10.3.6 Market Breakup by Application
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Gene Type
    • 10.4.4 Market Breakup by Vector Type
    • 10.4.5 Market Breakup by Delivery Method
    • 10.4.6 Market Breakup by Application
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Gene Type
    • 10.5.4 Market Breakup by Vector Type
    • 10.5.5 Market Breakup by Delivery Method
    • 10.5.6 Market Breakup by Application
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Gene Type
    • 10.6.4 Market Breakup by Vector Type
    • 10.6.5 Market Breakup by Delivery Method
    • 10.6.6 Market Breakup by Application
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Gene Type
    • 10.7.4 Market Breakup by Vector Type
    • 10.7.5 Market Breakup by Delivery Method
    • 10.7.6 Market Breakup by Application
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Gene Type
    • 10.8.4 Market Breakup by Vector Type
    • 10.8.5 Market Breakup by Delivery Method
    • 10.8.6 Market Breakup by Application
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Gene Therapy Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Services Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Services Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Services Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Services Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Services Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Gene Therapy Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix